Financial Snapshot

This section of the Fusion Pharmaceuticals InvestorRoom houses up to date financial reporting information and interactive tools to provide you with the resources you need to manipulate and understand our current financial standing. 

Please note:  All data in this section is provided by a 3rd party provider and may be delayed up to 20 minutes.  Fusion Pharmaceuticals assumes no responsibility for the accuracy of this data and provides it for informational purposes only.

NASDAQFUSN
Beta9.87
Shares Outstanding41.7M
Average Volume (10 days)33.4K
Qtrly Dividend (Ann. Yield)-- (--)

Per Share Data

Earnings (TTM)($26.75)
Sales (TTM)$0.00
Book Value (MRQ)$7.57
Cash Flow (TTM)($0.50)
Cash (MRQ)$134.77

Analyst Views

Current Mean RecommendationStrong Buy
Strong Buy3
 
Buy1
 
Hold0
 
Underperform0
 
Sell0
 

Recent Insider Transactions

Heather Preston
8,823
Buy
Jun 30, 2020
Chau Q. Khuong
705,900
Buy
Jun 30, 2020
Chau Q. Khuong
192,100
Buy
Jun 30, 2020
James J. O'Leary
Chief Medical Officer
300
Buy
Jun 30, 2020
Johan Christenson
240,000
Buy
Jun 30, 2020

Recent SEC Filings

10-Q
Quarterly Financials
Aug 11, 2020
8-K
Company Events
Aug 11, 2020
SC 13G
>= 5% Acquisition
Jul 23, 2020
SC 13D
SC 13D
Jul 10, 2020
SC 13D
SC 13D
Jul 10, 2020
Currency in USD.
Quote data delayed by at least 15 minutes.
Earnings and Analyst data provided by Zacks.
Insiders data provided by Morningstar.
NEVER MISS AN UPDATE

SIGN UP FOR INVESTOR ALERTS